thetaOwl

FXI

iShares China Large-Cap ETFClose $35.29EOD only
Max Pain
$38.00
Next expiry Jun 18, 2026
Expected Move
±$0.94
2.6% from close
Price Gap
+2.71
Distance to max pain
IV Rank
70
High premium
P/C OI
0.84
Slightly call-heavy
Consensus
6.0/10
Range bias
Published snapshot: Jun 12, 2026 close
End-of-day snapshot

This page reflects FXI options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.

Published Snapshot
Jun 12, 2026 close
FXI AI Consensus Report
Analysis based on market close June 15, 2026

Historical consensus-supported lens with full content, report chain context, and metric rail.

Conviction
7.0

out of 10

7 not 8 because current price of $0.00 introduces data uncertainty; otherwise alignment across three personas would warrant higher conviction.

Where Perspectives Agree

All personas agree on bearish bias toward $34 support, reinforced by negative gamma, bearish flow, and put skew.

Where They Diverge

No significant conflict — all perspectives favor bearish positioning; minor divergence in trade structure (directional wants bearish puts, theta wants put credit spread) is not incompatible.

Top Trade
via directional

Buy July 17 $34/$32 bear put spread for ~$0.75 debit — captures downside to gamma flip with defined risk.

Key Risk

Break below $32 flips dealer gamma long, removing pin support and accelerating selloff toward $30.

How to Use These Reports
This ai consensus reflects the market close on June 15, 2026.
What the reports do

Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.

How traders use them

Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.

What to remember

These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.

If the report conviction and the raw data disagree, slow down and resolve the mismatch before sizing risk.